Viking Global Investors LP Roivant Sciences Ltd. Transaction History
Viking Global Investors LP
- $31.6 Billion
- Q2 2025
A detailed history of Viking Global Investors LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Viking Global Investors LP holds 34,237,779 shares of ROIV stock, worth $396 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
34,237,779
Previous 46,013,752
25.59%
Holding current value
$396 Million
Previous $464 Million
16.89%
% of portfolio
1.22%
Previous 1.55%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$340 Million32.33% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...